Vivani Medical, Inc.
VANI
$1.34
-$0.02-1.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.23M | 9.52M | 9.43M | 9.41M | 9.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.23M | 27.81M | 27.55M | 27.20M | 26.79M |
| Operating Income | -27.23M | -27.81M | -27.55M | -27.20M | -26.79M |
| Income Before Tax | -26.31M | -27.09M | -26.61M | -26.03M | -25.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.31 | -27.09 | -26.61 | -26.03 | -25.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.31M | -27.09M | -26.61M | -26.03M | -25.54M |
| EBIT | -27.23M | -27.81M | -27.55M | -27.20M | -26.79M |
| EBITDA | -26.75M | -27.36M | -27.13M | -26.81M | -26.38M |
| EPS Basic | -0.36 | -0.41 | -0.43 | -0.44 | -0.44 |
| Normalized Basic EPS | -0.22 | -0.25 | -0.27 | -0.28 | -0.28 |
| EPS Diluted | -0.45 | -0.50 | -0.53 | -0.44 | -0.44 |
| Normalized Diluted EPS | -0.22 | -0.25 | -0.27 | -0.28 | -0.28 |
| Average Basic Shares Outstanding | 299.43M | 271.58M | 249.55M | 235.61M | 231.15M |
| Average Diluted Shares Outstanding | 299.43M | 271.58M | 249.55M | 235.61M | 231.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |